Skip Navigation


Journal of Biochemistry Advance Access originally published online on January 18, 2007
Journal of Biochemistry 2007 141(3):353-362; doi:10.1093/jb/mvm040
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
141/3/353    most recent
mvm040v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Peng, C.
Right arrow Articles by Wang, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peng, C.
Right arrow Articles by Wang, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 The Japanese Biochemical Society.

Pim Kinase Substrate Identification and Specificity

Charline Peng1, Axel Knebel2, Nick A. Morrice3, Xiang Li1, Kevin Barringer1, Jun Li1, Scott Jakes1, Brian Werneburg1 and Lian Wang1,*

1Boehringer Ingelheim Pharmaceuticals, Inc. 900 Ridgebury Road, Ridgefield, CT 06877, USA; 2Kinasource Ltd, Unit 9 South Dudhope Complex, 77 Douglas Street, Dundee, DD1 5AN, Scotland, UK; and 3MRC Protein Phosphorylation Unit, School of Life Sciences, University of Dundee, Dow Street, DD1 5EH, Scotland, UK

*To whom correspondence should be addressed. Tel: +1-203-798-4482, Fax: +1-203-791-6089, E-mail: lwang{at}rdg.boehringer-ingelheim.com

Received August 14, 2006; Accepted December 30, 2006


  Abstract

The Pim family of Ser/Thr kinases has been implicated in the process of lymphomagenesis and cell survival. Known substrates of Pim kinases are few and poorly characterized. In this study we set out to identify novel Pim-2 substrates using the Kinase Substrate Tracking and Elucidation (KESTREL) approach. Two potential substrates, eukaryotic initiation factor 4B (eIF4B) and apoptosis inhibitor 5 (API-5), were identified from rat thymus extracts. Sequence comparison of the Pim-2 kinase phosphorylation sites of eIF4B and mouse BAD, the only other known Pim-2 substrate, revealed conserved amino acids preceding the phosphorylated serine residue. Stepwise replacement of the conserved residues produced a consensus sequence for Pim kinase recognition: RXRHXS. Pim-1 and Pim-2 catalyzed the phosphorylation of this recognition sequence 20-fold more efficiently than the original (K/R-K/R-R-K/R-L-S/T-a; a = small chain amino acid) Pim-1 phosphorylation site. The identification of the novel Pim kinase consensus sequence provides a more sensitive and versatile peptide based assay for screening modulators of Pim kinase activity.

Key Words: Pim-2, Pim-1, eIF4B, peptide substrate, consensus sequence, KESTREL, kinase assay


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
D. Morishita, R. Katayama, K. Sekimizu, T. Tsuruo, and N. Fujita
Pim Kinases Promote Cell Cycle Progression by Phosphorylating and Down-regulating p27Kip1 at the Transcriptional and Posttranscriptional Levels
Cancer Res., July 1, 2008; 68(13): 5076 - 5085.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
D. Lin, T. V. Pestova, C. U. T. Hellen, and H. Tiedge
Translational Control by a Small RNA: Dendritic BC1 RNA Targets the Eukaryotic Initiation Factor 4A Helicase Mechanism
Mol. Cell. Biol., May 1, 2008; 28(9): 3008 - 3019.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.